AVEO announces pricing of $5.7 million public offering of common stock
AVEO Pharmaceuticals announced it has priced an underwritten public offering of 2,500,000 shares of common stock at a price to the public of $2.26 per share. AVEO granted underwriter a 30-day option to purchase up to an additional 375,000 shares of common stock. August 17, 2018